NuGen Medical to Raise Up to $3.6 Million in Non-Brokered Private Placement
Toronto, Ontario – March 31, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“)
NuGen Medical Announces New Online B2C Subscription Business
NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.
NuGen Medical Reports Distribution Business Boasts Margins of 70%+
NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.
NuGen Medical announces the return of Veronique Laberge as Chief Financial Officer and Corporate Secretary
NuGen Medical announces the return of Veronique Laberge as Chief Financial Officer and Corporate Secretary Toronto, Ontario – March 10th,
NuGen Medical’s Needle-Free Injection Device, InsuJet™ Delivers Increased Efficacy of Insulin for Diabetic Patient Care
NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.
NuGen Medical announces the appointment of Tony Di Benedetto as Executive Chairman and Director
NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen”) is pleased to announce that the Board of Directors has appointed Mr. Tony Di Benedetto as Executive Chairman and Director.
NuGen Medical Devices Inc. Announces the Appointment of Richard Buzbuzian as President, CEO and Director
NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company”) is pleased to announce that the Board of Directors has appointed Richard Buzbuzian as President, CEO and Director.